A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
MVista® Histoplasma Quantitative Antigen, EIA
Test CodeAlias/See Also
CPT Codes
87385
Preferred Specimen
Minimum Volume
CSF: 0.8 mL
Serum or plasma: 1.2 mL
Other Acceptable Specimens
Instructions
Indicate specimen type and date drawn on test request form. Two unique patient identifiers required on specimen container. Ship to arrive Monday-Friday using a next day delivery service or 2nd day service. Do not ship by first class mail. List all antifungal agents patient is receiving.
Note: Interfering substances and cross-reactivities include sodium hydroxide and sputolysin. Cross-reactivity occurs between blastomycosis and histoplasmosis and in paracoccidioidomycosis, penicillosis, coccidioidomycosis, aspergillosis and sporotrichosis.
Serum: Collect serum specimens in serum separator or red top tube. Allow blood to clot for 30 minutes, then centrifuge. Pipette serum into a plastic screw cap vial.
Plasma: Collect plasma specimens in an EDTA, heparin or sodium citrate tube. Centrifuge for 15 minutes and pipette plasma into a plastic screw cap vial.
Urine/CSF/BAL/Other Body Fluid: Submit urine, CSF, BAL and all other body fluids in a sterile screw cap container
Transport Temperature
Specimen Stability
Refrigerated: 14 days
Frozen: Indefinitely
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Methodology
Enzyme Immunoassay (EIA)
FDA Status
This test was developed and its performance characteristics determined by MiraVista Diagnostics. It has not been cleared or approved by the FDA; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.
Setup Schedule
Reference Range
Clinical Significance
Performing Laboratory
MiraVista Laboratories
4444 Decatur Blvd., Suite 300
Indianapolis, IN 46241
Last Updated: April 7, 2023
Last Review: N. Wolford, April 7, 2023